US equities |
MU $1,044.16 ▼-1.97% NVDA $230.45 ▲+0.91% SNDK $1,738.32 ▼-0.09% TSLA $356.20 ▲+0.39% INTC $119.63 ▼-0.50% SPCX $151.24 ▲+0.25% GOOGL $339.92 ▼-1.21% AMD $611.08 ▼-0.11%
FinancialContent Watchlist

Biotricity, Inc. - Common Stock (NQ:BTCY)

0.4631 UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Biotricity, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
Biotricity Partners with Health Aid Africa to Provide Complementary Heart Health Screenings at Allegiant Stadium Concert
Via ACCESSWIRE
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Biotricity Unveils that Improved Margins Resulted from Latest Advancements to its Proprietary Cardiac AI Cloud Platform and Announces Plans for Continued Expansion of its Cardiac AI Cloud
Via ACCESSWIRE
News headline image
Biotricity Partners with a Second Top Group Purchasing Organization - Positions Company for Expanded Market Access to 1 out of every 2 Hospitals in America
Via ACCESSWIRE
News headline image
Biotricity Receives Health Canada Clearance for Biotres
Via ACCESSWIRE
News headline image
Biotricity's Earnings Outlook ↗
 
Via Benzinga
News headline image
Biotricity Expands Development of its Cardiac AI Cloud Platform with Data Ecosystem of over 360 billion Heartbeats
Via ACCESSWIRE
News headline image
Earnings Outlook For Biotricity ↗
 
Via Benzinga
News headline image
Biotricity Strengthens its Foundation for Growth, Achieves Lower Cost of Sales, Expanding Margins of 73% and Increased Device Sales, for Third Quarter of Fiscal Year 2024
Via ACCESSWIRE
News headline image
Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results. 
Via Benzinga
News headline image
Biotricity to Host Third Quarter Fiscal Year 2024 Financial Results and Business Update Call on February 21st
Via ACCESSWIRE
News headline image
Biotricity to Host Second Quarter Fiscal Year 2024 Financial Results and Business Update Call on November 14th
Via ACCESSWIRE
News headline image
CORRECTION BY SOURCE: Biotricity Announces Patent Filing for Cutting-Edge Biotres Device
Via ACCESSWIRE
News headline image
Biotricity Unveils a New Digital Presence, Highlighting its Expanding Technology Portfolio and Cutting-Edge Innovations
Via ACCESSWIRE
News headline image
Earnings Scheduled For February 20, 2024 ↗
Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue of $7.38 billion. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Biotricity Advances Towards Breakeven Milestone - Set to Announce Record Margins and Operational Efficiency for Third Quarter of Fiscal Year 2024
Via ACCESSWIRE
News headline image
Biotricity Delivers Record Margins and Double Digit Year-Over-Year Sales Growth for Second Quarter of Fiscal Year 2024
Via ACCESSWIRE
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
It's time for another dive into the biggest pre-market stock movers as we break down all of the latest news for Tuesday morning. 
Via InvestorPlace
News headline image
Biotricity Achieves $14 Million Revenue Run Rate in August 2023
Via ACCESSWIRE
News headline image
Biotricity Shows Continued Growth and Strength in its Fundamentals on its Path to Profitability
Via ACCESSWIRE
News headline image
Biotricity Releases Another Groundbreaking Product: Biotres Pro
Via ACCESSWIRE
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Biotricity Continues to Expand Patent Portfolio with Latest Patent Filing for Bioheart Device
Via ACCESSWIRE
News headline image
Why Barnes Group Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Gainers Apollomics, Inc. (NASDAQ: APLM) shares surged 88.4% to $1.07 stoma multiforme with PTPRZ-MET fusion. 
Via Benzinga
News headline image
Biotricity Announces Patient Filing for Cutting-Edge Biotres Device
Via ACCESSWIRE
News headline image
Biotricity Reports Strong Growth for its First Quarter Fiscal Year 2024 and Provides Financial Results and Business Updates
Via ACCESSWIRE
News headline image
Biotricity to Host First Quarter Fiscal Year 2024 Financial Results and Business Update Call on August 15th
Via ACCESSWIRE
News headline image
Biotricity Is Paving The Way For Cardiac Health In The Age Of AI Technology
Via ACCESSWIRE
< Previous 1 2 3 4 5 6 7 8 Next >